Join Worldwide’s own Sherilyn Adcock, EVP of Medical and Scientific Affairs, as she discusses industry changes in Phase 1 early development programs over recent years.
Authors:
Sherilyn Adcock, RPh, PhD
Chief Scientific Officer, Early Phase Development
